- China Pacific Life Insurance reported a year-to-date (YTD) premium income of 49.58 billion yuan.
- The YTD premium income for property and casualty insurance reached 26.70 billion yuan.
- Analyst ratings include 19 buys, indicating strong investor confidence in the company.
- There are 5 hold recommendations, suggesting some caution among investors.
- No sell recommendations were reported, which reflects a general positive outlook on the company’s performance.
A look at China Pacific Insurance (Group) Co., Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Pacific Insurance (Group) Co., Ltd. is a company that provides a range of insurance services, including life and property insurance products through its subsidiaries. According to Smartkarma Smart Scores, the company has received high ratings across various factors. It has scored top marks in both Value and Dividend categories, indicating strong financial performance and investor returns. Moreover, with a solid Growth score and moderate Resilience rating, China Pacific Insurance (Group) Co. shows potential for expansion and a stable operational outlook. However, the company lags behind in Momentum, suggesting slower short-term market performance.
Looking ahead, China Pacific Insurance (Group) Co. appears well-positioned for long-term success based on its impressive Value and Dividend scores. Investors may see this as a promising opportunity for consistent returns and financial stability. While the company may need to address its Momentum score to attract more short-term interest, its strong fundamentals in other areas could drive future growth and value creation.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
